PSA Today 18 April: Higher as trade fears diminish / March CPI +3.6% / Impact Chugai's orforglipron to earnings, share price / Money Forward, SMFG digital banking JV – Nikkei 225 +1.03% | ¥$142.34
PSA Today 18 April Japan Market Comment by Pelham Smithers, Julie Boote and Lindsay WhippTags: Mazda Motor (7261 JT), Subaru (7270 JT), Suzuki Motor (7269 JT), Inpex (1605 JT), Fuji Media (4676 JT), TV Asahi (9409 JT), Nippon Steel (5401 JT), Osaka Steel (5449 JT), Yodogawa Steel (5451 JT), Chugai Pharmaceutical (4519 JT), Eli Lilly (LLY US), Nxera Pharma (4565 JT), Pfizer (PFE US), Disco (6146 JT), Novo Nordisk (NOVOB DC), Ono Pharmaceutical (4528 JT), Bristol Myers (BMY US), Money Forward (3994 JT), Sumitomo Mitsui Financial Group (8316 JT)
Main Points
* Japan shares gain as trade fears diminish, activism continues
* Japan CPI +3.6% YoY in March
* Implications of the orforglipron trial data for Chugai’s earnings, share price
* Money Forward and SMFG to set up digital bank JV
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.